首页工具

登录

搜索结果

Search Results for " pparγ agonist 2 "

23

抑制剂 & 化合物

2

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T61743	PPARγ agonist 2
	PPARγ agonist 2 is a highly effective compound that acts as a partial agonist for PPARγ. It exhibits significant potential for utilization in metabolic disease research [1].
T28501	Ragaglitazar NNC61-0029,NN-622,(-)-DRF-2725,NNC-61-0029,NN 622,NNC 61-0029	PPAR	DNA Damage/DNA Repair; Metabolism
	Ragaglitazar(NNC-61-0029) 是一种有效的 PPARα和 PPARγ双重激动剂，在动物模型中显示出有效的降脂和胰岛素增敏作用。Ragaglitazar 可用于研究 2 型糖尿病。
T16022	Arhalofenate JNJ 39659100,芳卤芬酯,4-氯-ALPHA-[3-(三氟甲基)苯氧基]苯乙酸 2-(乙酰基氨基)乙酯,MBX 102	PPAR	DNA Damage/DNA Repair; Metabolism
	Arhalofenate (JNJ 39659100) 是一种选择性的(PPAR)-γ部分激动剂，用于研究 2 型糖尿病。
T7796	TUG-1375	GPR	Endocrinology/Hormones; GPCR/G Protein
	TUG-1375 是游离脂肪酸受体 2 (FFA2/GPR43) 激动剂(pKi:6.69)。它对 FFA3，FFA4，PPARα，PPARγ，PPARδ，LXRα 或 LXRβ 无作用。
T21587	Muraglitazar Pargluva,BMS-298585	PPAR	DNA Damage/DNA Repair; Metabolism
	Muraglitazar (BMS-298585) 是一种 PPAR α/γ的双激动剂，用于治疗2型糖尿病及相关血脂异常。Muraglitazar 对人 PPARα (EC50 = 320 nM)和 PPARγ(EC50 = 110 nM)具有较强的体外活性。
T6524	GW0742 GW610742,[4-[[[2-[3-氟-4-(三氟甲基)苯基]-4-甲基-5-噻唑基]甲基]硫代]-2-甲基苯氧基]乙酸	PPAR	DNA Damage/DNA Repair; Metabolism
	GW0742 是一种有效且特异性的 PPARδ 激动剂，对人 PPARδ、PPARα 和 PPARγ 的 EC50值分别为 1、1.1 和 2 μM。
T60184	TUG-499	GPR; PPAR	DNA Damage/DNA Repair; Endocrinology/Hormones; GPCR/G Protein; Metabolism
	TUG-499 是一种选择性游离脂肪酸受体 1 (FFAR1 或 GPR40)激动剂（EC50 ： 7.39）。TUG-499对 FFAR1 或 GPR40的亲和力超过相关受体 FFA2、FFA3 和核受体 PPARγ，以及其他不同的受体、离子通道和转运蛋白。TUG-499 可用于研究 2 型糖尿病。
T15736	Leriglitazone Hydroxypioglitazone	Others	Others
	Leriglitazone, a metabolite of pioglitazone, binds to the PPARγ C-terminal ligand-binding domain (Ki: 1.2 μM) and induces transcriptional efficacy of the PPARγ (EC50: 680 nM). Leriglitazone PioOH is a PPARγ agonist, stabilizes the PPARγ activation functio
T61875	Rivoglitazone
	Rivoglitazone 是一种噻唑烷二酮衍生物，PPARγ的激动剂，用于治疗2型糖尿病。
T61836	Pioglitazone potassium
	Pioglitazone potassium (U 72107) is an orally active and selective agonist of peroxisome proliferator-activated receptor gamma (PPARγ). It demonstrates high affinity binding to the ligand-binding domain of PPARγ, with an EC50 of 0.93 μM and 0.99 μM for human and mouse PPARγ, respectively. Pioglitazone potassium has applications in diabetes research [2] [3] [4].
TMIH-0516	Saroglitazar-d4
	Saroglitazar-d4 是 Saroglitazar 的氘代化合物。Saroglitazar 的 CAS 号为 495399-09-2。Saroglitazar 是 PPAR 的激动剂，对 PPARα 和 PPARγ 的 EC50 值为 0.65 pM 和 3 nM。
T12876	Seladelpar sodium salt RWJ-800025 sodium salt,MBX-8025 sodium salt	Others	Others
	Seladelpar sodium salt (MBX-8025) 是一种具有口服活性、有效且特异性的PPARδ激动剂，EC50值为 2 nM。它对 PPARδ 的选择性分别是对 PPARα 和 PPARγ 的 750 和 2500 多倍。
TMIH-0517	Saroglitazar oxide-d4
	Saroglitazar oxide-d4 是 Saroglitazar oxide 的氘代化合物。Saroglitazar oxide 的 CAS 号为 495399-09-2。Saroglitazar 是 PPAR 的激动剂，对 PPARα 和 PPARγ 的 EC50 值为 0.65 pM 和 3 nM。
T73842	Leriglitazone hydrochloride
	Leriglitazone (Hydroxypioglitazone) hydrochloride，吡格列酮的代谢产物。Leriglitazone (Hydroxypioglitazone) hydrochloride 是PPARγ激动剂，通过稳定PPARγ(AF-2) 共激活剂结合表面和增强共激活剂结合能力，提供高转录效力。 Leriglitazone (Hydroxypioglitazone) hydrochloride 与 PPARγC (LBD) 结合，其Ki 值为 1.2 μM，诱导PPARγ(LBD) 转录效率，EC50为 680 nM。
T64011	GSK1820795A
	GSK1820795A 作为替米沙坦类似物是hGPR132a 的选择性拮抗剂。GSK1820795A 阻断了 N-acylamides 对表达hGPR132a 的酵母细胞的活化。GSK1820795A 也是血管紧张素 II 拮抗剂和部分PPARγ激动剂 (compound 38) 。
T61848	Rosiglitazone potassium
	Rosiglitazone (BRL 49653) potassium is a potent and selective PPARγ agonist (EC 50: 60 nM, Kd: 40 nM), administered orally. It also serves as an activator of TRPC5 (EC 50: 30 μM) and an inhibitor of TRPM3. This compound, widely used in research, has shown promise in investigating obesity, diabetes, senescence, and ovarian cancer [1] [2] [4] [7].
T37633	17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid
	17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic acid is a metabolite of lipoxygenase-mediated oxidation of DHA that is produced endogenously by aspirin-enhanced COX-2 activity. It has been shown to activate Nrf2-dependent antioxidant gene expression, to act as a PPARγ agonist (EC50 = ~200 nM), and to inhibit pro-inflammatory cytokine and nitric oxide production at biological concentration ranges (5-25 μM).
T37634	17-oxo-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid
	Docosapentaenoic acid (DPA) is a ω-3 fatty acid found in fish oils. 17-oxo-7(Z),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid is a metabolite of lipoxygenase-mediated oxidation of DPA that is produced endogenously by aspirin-enhanced COX-2 activity. It has been shown to activate Nrf2-dependent antioxidant gene expression, to act as a PPARγ agonist (EC50 = ~200 nM), and to inhibit pro-inflammatory cytokine and nitric oxide production at biological concentration ranges (5-25 μM).
T35799	MBX-8025 (sodium salt)
	MBX-8025 is an agonist of peroxisome proliferator-activated receptor δ (PPARδ).1 It is greater than 750- and 2,500-fold selective for PPARδ over PPARα and PPARγ. MBX-8025 (10 mg/kg per day for eight weeks) reduces increases in fasting blood glucose and serum insulin levels, and decreases insulin resistance in Alms1 mutant (foz/foz) mice fed an atherogenic diet as a model of diet-induced obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH).2 It also decreases serum alanine transamin...
T71306	Gemfibrozil-d6
	Gemfibrozil-d6 is intended for use as an internal standard for the quantification of gemfibrozil by GC- or LC-MS. Gemfibrozil is a peroxisome proliferator-activated reporter α and PPARγ agonist. In vivo, gemfibrozil reduces serum total cholesterol, triglyceride, and LDL levels in a rat model of high-cholesterol diet-induced hyperlipidemia. Gemfibrozil reduces atherosclerotic plaque area, superoxide production, and expression of the genes encoding the NF-κB subunit p65 and chemokine (C-C) motif l...
T35816	ZLY032
	ZLY032 is a dual agonist of free fatty acid receptor 1 (FFAR1/GPR40; EC50= 68 nM in a FLIPR assay) and peroxisome proliferator-activated receptor δ (PPARδ; EC50= 102 nM in a reporter assay).1It is selective for FFAR1 and PPARδ over PPARα and PPARγ (EC50s = >10 μM for both). ZLY032 (40 mg/kg, twice per day) reduces blood glucose levels in an oral glucose tolerance test and decreases plasma total cholesterol and triglyceride levels in theob/obmouse model of metabolic disease.2It reduces hepatic st...
T35468	(±)19(20)-EDP Ethanolamide
	(±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). It is produced through direct epoxygenation of docosahexaenoyl ethanolamide by cytochrome P450 (CYP) epoxygenases. (±)19(20)-EDP ethanolamide (25 μM) reduces the viability of 143B metastatic osteosarcoma cells. It decreases the production of IL-6 and increases the production of IL-10 when used at concentrations ranging from 2.5 to 10 μM in BV-...
T65598	Cefminox sodium
	Cefminox (Sodium) is a new cephamycin antibiotic possessing a D-amino acid moiety derived from D-cysteine at the C-7B side chain. Cefminox is active against a wide range of bacteria, especially Gram-negative and anaerobic bacteria. Cefminox shows excellent in vivo efficacy (ED50) which is higher than would be expected from its in vitro activity (MIC). Moreover, cefminox possesses more potent activity in suppression of bacterial regrowth than other cephems[1]. Cefminox (Sodium) was the most activ...

化合物

PPARγ agonist 2

Cat.No: T61743

Cat.No: T28501

Synonym: NNC61-0029,NN-622,(-)-DRF-2725,NNC-61-0029,NN 622,NNC 61-0029

Target: PPAR

Cat.No: T16022

Synonym: JNJ 39659100,芳卤芬酯,4-氯-ALPHA-[3-(三氟甲基)苯氧基]苯乙酸 2-(乙酰基氨基)乙酯,MBX 102

Target: PPAR

Cat.No: T7796

Target: GPR

Cat.No: T21587

Synonym: Pargluva,BMS-298585

Target: PPAR

Cat.No: T6524

Synonym: GW610742,[4-[[[2-[3-氟-4-(三氟甲基)苯基]-4-甲基-5-噻唑基]甲基]硫代]-2-甲基苯氧基]乙酸

Target: PPAR

Cat.No: T60184

Target: GPR, PPAR

Cat.No: T15736

Synonym: Hydroxypioglitazone

Target: Others

Cat.No: T61875

Pioglitazone potassium

Cat.No: T61836

Saroglitazar-d4

Cat.No: TMIH-0516

Seladelpar sodium salt

Cat.No: T12876

Synonym: RWJ-800025 sodium salt,MBX-8025 sodium salt

Target: Others

Saroglitazar oxide-d4

Cat.No: TMIH-0517

Leriglitazone hydrochloride

Cat.No: T73842

Cat.No: T64011

Rosiglitazone potassium

Cat.No: T61848

17-oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-Docosahexaenoic Acid

Cat.No: T37633

17-oxo-7(Z),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid

Cat.No: T37634

MBX-8025 (sodium salt)

Cat.No: T35799

Cat.No: T71306

Cat.No: T35816

(±)19(20)-EDP Ethanolamide

Cat.No: T35468

Cefminox sodium

Cat.No: T65598

Cat. No.	Product Name	Target	Signaling Pathways
TN1475	Caulophyllogenin Segetalic acid	IL Receptor; TNF; PPAR; Immunology/Inflammation related	Apoptosis; DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism
	Caulophyllogenin 是一种部分 PPARγ 激动剂 (EC50 = 12.6 μM)，来源于 Kalopanax pictus (五加科) 的茎皮。 Caulophyllogenin 抑制促炎细胞因子分泌，可用于预防和治疗炎症性疾病、2 型糖尿病、肥胖和代谢综合征的研究。
T75690	Wistin
	Wistin 可从 Caragana sinica 根部分离得到，是 PPARα和 PPARγ的激动剂。

天然产物

Caulophyllogenin

Cat.No: TN1475

Synonym: Segetalic acid

Target: IL Receptor, TNF, PPAR, Immunology/Inflammation related

Cat.No: T75690

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼